These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 21865175

  • 1. Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.
    Scott JA, Ojal J, Ashton L, Muhoro A, Burbidge P, Goldblatt D.
    Clin Infect Dis; 2011 Oct; 53(7):663-70. PubMed ID: 21865175
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.
    Thisyakorn U, Chokephaibulkit K, Kosalaraksa P, Benjaponpitak S, Pancharoen C, Chuenkitmongkol S.
    Hum Vaccin Immunother; 2014 Oct; 10(7):1859-65. PubMed ID: 25424793
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
    Temple B, Toan NT, Dai VTT, Bright K, Licciardi PV, Marimla RA, Nguyen CD, Uyen DY, Balloch A, Huu TN, Mulholland EK.
    Lancet Infect Dis; 2019 May; 19(5):497-509. PubMed ID: 30975525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
    Ojal J, Hammitt LL, Gaitho J, Scott JAG, Goldblatt D.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4652-4657. PubMed ID: 28739116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.
    Goldblatt D, Southern J, Andrews NJ, Burbidge P, Partington J, Roalfe L, Valente Pinto M, Thalasselis V, Plested E, Richardson H, Snape MD, Miller E.
    Lancet Infect Dis; 2018 Feb 16; 18(2):171-179. PubMed ID: 29174323
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.
    Hamaluba M, Kandasamy R, Upreti SR, Subedi GR, Shrestha S, Bhattarai S, Gurung M, Pradhan R, Voysey M, Gurung S, Pradhan S, Thapa AK, Maharjan R, Kiran U, Kerridge SA, Hinds J, van der Klis F, Snape MD, Murdoch DR, Kelly S, Kelly DF, Adhikari N, Thorson S, Pollard AJ.
    Lancet Infect Dis; 2015 Apr 16; 15(4):405-14. PubMed ID: 25701560
    [Abstract] [Full Text] [Related]

  • 13. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
    Sigurdardottir ST, Center KJ, Davidsdottir K, Arason VA, Hjalmarsson B, Elisdottir R, Ingolfsdottir G, Northington R, Scott DA, Jonsdottir I.
    Vaccine; 2014 Jan 09; 32(3):417-24. PubMed ID: 24300594
    [Abstract] [Full Text] [Related]

  • 14. Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
    Russell FM, Balloch A, Licciardi PV, Carapetis JR, Tikoduadua L, Waqatakirewa L, Cheung YB, Mulholland EK, Tang ML.
    Vaccine; 2011 Jun 15; 29(27):4499-506. PubMed ID: 21539882
    [Abstract] [Full Text] [Related]

  • 15. Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.
    Rose MA, Schubert R, Strnad N, Zielen S.
    Clin Diagn Lab Immunol; 2005 Oct 15; 12(10):1216-22. PubMed ID: 16210486
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.
    Zangwill KM, Greenberg DP, Chiu CY, Mendelman P, Wong VK, Chang SJ, Partridge S, Ward JI.
    Vaccine; 2003 May 16; 21(17-18):1894-900. PubMed ID: 12706674
    [Abstract] [Full Text] [Related]

  • 17. Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.
    Trück J, Thompson A, Morales-Aza B, Clutterbuck EA, Voysey M, Clarke E, Snape MD, Kelly DF, Finn A, Pollard AJ.
    Vaccine; 2017 May 09; 35(20):2701-2708. PubMed ID: 28392142
    [Abstract] [Full Text] [Related]

  • 18. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H, ARIVAC Consortium.
    Vaccine; 2009 May 05; 27(20):2680-8. PubMed ID: 19428879
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.
    Nachman S, Kim S, King J, Abrams EJ, Margolis D, Petru A, Shearer W, Smith E, Moye J, Blanchard S, Hawkins E, Bouquin P, Vink P, Benson M, Estep S, Malinoski F, Pediatric AIDS Clinical Trials Group Study 292 Team.
    Pediatrics; 2003 Jul 05; 112(1 Pt 1):66-73. PubMed ID: 12837869
    [Abstract] [Full Text] [Related]

  • 20. Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol.
    Prymula R, Habib A, François N, Borys D, Schuerman L.
    Vaccine; 2013 Apr 12; 31(16):2080-8. PubMed ID: 23391599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.